Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). (Q38075142)

28 August 2017

1 reference

title

Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). (English)

1 reference

28 August 2017

hepatocellular carcinoma

1 reference

Ann-Lii Cheng

18

0 references

Chen Pei-jer

object named as

Pei-Jer Chen

4

0 references

Masatoshi Kudo

object named as

Masatoshi Kudo

8

0 references

Laurentius A Lesmana

11

object named as

Laurentius A Lesmana

1 reference

28 August 2017

14

Ronnie T Poon

1 reference

28 August 2017

7

Kwang-Hyub Han

1 reference

28 August 2017

1

Joong-Won Park

1 reference

28 August 2017

2

Deepak Amarapurkar

1 reference

28 August 2017

3

Yee Chao

1 reference

28 August 2017

9

Han Chu Lee

1 reference

28 August 2017

10

Rheun-Chuan Lee

1 reference

28 August 2017

13

Seung Woon Paik

1 reference

28 August 2017

15

Chee-Kiat Tan

1 reference

28 August 2017

16

Tawesak Tanwandee

1 reference

28 August 2017

17

Gaojun Teng

1 reference

28 August 2017

Jean-Francois H Geschwind

5

1 reference

28 August 2017

Khean Lee Goh

6

1 reference

28 August 2017

Ho Yeong Lim

12

1 reference

28 August 2017

18 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

33

1 reference

28 August 2017

327-337

1 reference

28 August 2017

3

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

28 August 2017

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Austrian Joint ÖGGH-ÖGIR-ÖGHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.

21 January 2018

1 reference

Selective and sequential transarterial chemoembolization: survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

21 January 2018

1 reference

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

21 January 2018

1 reference

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study

21 January 2018

1 reference

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis

21 January 2018

1 reference

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Radioembolization for hepatocellular carcinoma

21 January 2018

1 reference

Selective internal radiation therapy (SIRT) in primary or secondary liver cancer

21 January 2018

1 reference

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma

21 January 2018

1 reference

Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy

21 January 2018

1 reference

Hepatitis B virus-related hepatocellular carcinogenesis and its prevention

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Ethnic differences in the behavior of hepatocellular carcinoma

21 January 2018

1 reference

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

21 January 2018

1 reference

The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma

21 January 2018

1 reference

Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma

21 January 2018

1 reference

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan

21 January 2018

1 reference

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma

21 January 2018

1 reference

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

21 January 2018

1 reference

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

Reporting results of cancer treatment

21 January 2018

1 reference

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

21 January 2018

1 reference

The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma

21 January 2018

1 reference

Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study

21 January 2018

1 reference

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

21 January 2018

1 reference

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12083

1 reference

release_sxx2ilinezg5lekjtgiwjvycf4

28 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sxx2ilinezg5lekjtgiwjvycf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference